NCT01405794View on ClinicalTrials.gov

In-Vivo Assessment of Silver Biomaterial Nano-Toxicity 32 Ppm

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Healthy
Interventions
DRUG

32ppm Silver Particle

Oral silver dose of 32ppm

DRUG

Placebo

Sterile Water No Silver

Trial Locations (1)

84112-5820

University of Utah, Salt Lake City

All Listed Sponsors
lead

University of Utah

OTHER

NCT01405794 - In-Vivo Assessment of Silver Biomaterial Nano-Toxicity 32 Ppm | Biotech Hunter | Biotech Hunter